JP2022546701A5 - - Google Patents

Info

Publication number
JP2022546701A5
JP2022546701A5 JP2022513214A JP2022513214A JP2022546701A5 JP 2022546701 A5 JP2022546701 A5 JP 2022546701A5 JP 2022513214 A JP2022513214 A JP 2022513214A JP 2022513214 A JP2022513214 A JP 2022513214A JP 2022546701 A5 JP2022546701 A5 JP 2022546701A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
crispr
seq
related protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022513214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546701A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/048037 external-priority patent/WO2021041569A1/en
Publication of JP2022546701A publication Critical patent/JP2022546701A/ja
Publication of JP2022546701A5 publication Critical patent/JP2022546701A5/ja
Pending legal-status Critical Current

Links

JP2022513214A 2019-08-27 2020-08-26 新規crispr dnaターゲティング酵素及びシステム Pending JP2022546701A (ja)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US201962892358P 2019-08-27 2019-08-27
US201962892434P 2019-08-27 2019-08-27
US201962892446P 2019-08-27 2019-08-27
US201962892382P 2019-08-27 2019-08-27
US201962892390P 2019-08-27 2019-08-27
US62/892,358 2019-08-27
US62/892,382 2019-08-27
US62/892,446 2019-08-27
US62/892,390 2019-08-27
US62/892,434 2019-08-27
US201962893059P 2019-08-28 2019-08-28
US201962893064P 2019-08-28 2019-08-28
US62/893,064 2019-08-28
US62/893,059 2019-08-28
US201962896277P 2019-09-05 2019-09-05
US62/896,277 2019-09-05
PCT/US2020/048037 WO2021041569A1 (en) 2019-08-27 2020-08-26 Novel crispr dna targeting enzymes and systems

Publications (2)

Publication Number Publication Date
JP2022546701A JP2022546701A (ja) 2022-11-07
JP2022546701A5 true JP2022546701A5 (enExample) 2023-09-04

Family

ID=74683321

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513214A Pending JP2022546701A (ja) 2019-08-27 2020-08-26 新規crispr dnaターゲティング酵素及びシステム

Country Status (7)

Country Link
US (1) US20230016656A1 (enExample)
EP (1) EP4021924A4 (enExample)
JP (1) JP2022546701A (enExample)
CN (1) CN114729011A (enExample)
AU (1) AU2020340353A1 (enExample)
CA (1) CA3152788A1 (enExample)
WO (1) WO2021041569A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020097445A1 (en) 2018-11-09 2020-05-14 Inari Agriculture, Inc. Rna-guided nucleases and dna binding proteins
EP4347818A2 (en) 2021-06-01 2024-04-10 Arbor Biotechnologies, Inc. Gene editing systems comprising a crispr nuclease and uses thereof
KR20250151430A (ko) 2023-02-15 2025-10-21 아버 바이오테크놀로지스, 인크. 스타스민 2(stmn2) 전사체에서 비정상적인 스플라이싱을 억제하는 유전자 편집 방법
WO2024078645A2 (zh) * 2023-12-28 2024-04-18 广州瑞风生物科技有限公司 Cas蛋白及其应用
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2025201481A1 (en) * 2024-03-29 2025-10-02 Yoltech Therapeutics Co., Ltd Crispr-cas systems
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3500967A1 (en) * 2016-08-17 2019-06-26 The Broad Institute, Inc. Methods for identifying class 2 crispr-cas systems
BR112019006388A2 (pt) * 2016-09-30 2019-06-25 Univ California enzimas modificadoras de ácido nucleico guiadas por rna e métodos de uso das mesmas
US10392616B2 (en) * 2017-06-30 2019-08-27 Arbor Biotechnologies, Inc. CRISPR RNA targeting enzymes and systems and uses thereof

Similar Documents

Publication Publication Date Title
JP2022547524A5 (enExample)
JP2022546701A5 (enExample)
JP2025161809A5 (enExample)
US11459588B2 (en) Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides
JP2022546594A5 (enExample)
CN113373130A (zh) Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用
JP2022540153A5 (enExample)
JP2022538789A5 (enExample)
US20200172935A1 (en) Modified cpf1 mrna, modified guide rna, and uses thereof
JP2021521788A (ja) ゲノム編集のための組成物および方法
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP2024524514A5 (enExample)
US12275951B2 (en) Engineered guide RNA and uses thereof
CN112384620B (zh) 用于筛选和鉴定功能性lncRNA的方法
WO2023206872A1 (zh) 一种工程优化的核酸酶、向导rna、编辑系统和应用
WO2022187278A1 (en) Nucleic acid detection and analysis systems
CN113652411A (zh) Cas9蛋白、含有Cas9蛋白的基因编辑系统及应用
HK40102346A (en) Crispr hybrid dna/rna polynucleotides and methods of use
EP4526884A2 (en) Systems and methods for assessing risk of genome editing events
US20250387514A1 (en) Compositions and methods for epigenetic regulation of trac expression
JP2025535776A (ja) 遺伝子を標的化、編集又は修飾するための組成物及び方法
CN118165956A (zh) 基于Tsp2Cas9蛋白的CRISPR/Cas9基因编辑系统及其相关应用
HK40045732B (en) Method for screening and identifying functional lncrnas
HK1245839B (en) Crispr hybrid dna/rna polynucleotides and methods of use